Document Detail

Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches.
MedLine Citation:
PMID:  22771339     Owner:  NLM     Status:  Publisher    
Toxicokinetics (TK) is the endpoint that informs about the penetration into and fate within the body of a toxic substance, including the possible emergence of metabolites. Traditionally, the data needed to understand those phenomena have been obtained in vivo. Currently, with a drive towards non-animal testing approaches, TK has been identified as a key element to integrate the results from in silico, in vitro and already available in vivo studies. TK is needed to estimate the range of target organ doses that can be expected from realistic human external exposure scenarios. This information is crucial for determining the dose/concentration range that should be used for in vitro testing. Vice versa, TK is necessary to convert the in vitro results, generated at tissue/cell or sub-cellular level, into dose response or potency information relating to the entire target organism, i.e. the human body (in vitro - in vivo extrapolation, IVIVE). Physiologically based toxicokinetic modelling (PBTK) is currently regarded as the most adequate approach to simulate human TK and extrapolate between in vitro and in vivo contexts. The fact that PBTK models are mechanism-based which allows them to be 'generic' to a certain extent (various extrapolations possible) has been critical for their success so far. The need for high-quality in vitro and in silico data on absorption, distribution, metabolism as well as excretion (ADME) as input for PBTK models to predict human dose-response curves is currently a bottleneck for integrative risk assessment.
Sandra Coecke; Olavi Pelkonen; Sofia Batista Leite; Ulrike Bernauer; Jos Bessems; Frederic Bois; Ursula Gundert-Remy; George Loizou; Emanuela Testai; José-Manuel Zaldívar
Related Documents :
17173729 - Complexity and cognition: a meta-theoretical analysis of the mind and brain as a topolo...
11722829 - Theoretical applications of smoking cessation interventions to individuals with medical...
21315989 - Bayesian modeling of clostridium perfringens growth in beef-in-sauce products.
10900819 - Procedures: do we really want to know them? an examination of the effects of procedural...
23709429 - Establishment and evaluation of a simplified evaluation system of acute respiratory dis...
22562719 - Toxicokinetic-toxicodynamic modelling of survival of gammarus pulex in multiple pulse e...
24110789 - A high reliability detection algorithm for wireless ecg systems based on compressed sen...
18165259 - Inferring selection in partially sequenced regions.
24237169 - A new patent-based approach for technology mapping in the pharmaceutical domain.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-3
Journal Detail:
Title:  Toxicology in vitro : an international journal published in association with BIBRA     Volume:  -     ISSN:  1879-3177     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712158     Medline TA:  Toxicol In Vitro     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21027 Ispra (VA) Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of lipopolysaccharide (LPS) and peptidoglycan (PGN) on estradiol production in bovine granul...
Next Document:  Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecul...